NCT06764186
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06764186
Title A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain (CAPItana)
Acronym CAPItana
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Research Site Alicante 03010 Spain Details
Research Site Barcelona 08003 Spain Details
Research Site Barcelona 08035 Spain Details
Research Site Barcelona 08036 Spain Details
Research Site Bilbao (Vizcaya) 48013 Spain Details
Research Site Córdoba 14004 Spain Details
Research Site Donostia / San Sebastian 20014 Spain Details
Research Site El Palmar 30120 Spain Details
Research Site Girona 17007 Spain Details
Research Site Madrid 28041 Spain Details
Research Site Oviedo 33011 Spain Details
Research Site Palma deMallorca 07010 Spain Details
Research Site Salamanca 37007 Spain Details
Research Site Santander 39008 Spain Details
Research Site Seville 41073 Spain Details
Research Site Valencia 46026 Spain Details
Research Site Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field